Indium111PentetreotideQualityChecker
Indium-111 Pentetreotide
Utility description: Indium-111 Pentetreotide
Indium-111 Pentetreotide Quality Checker — Indium-111 Pentetreotide (OctreoScan®)
ℹ️ Utility checks critical parameters of the somatostatin analog radiopharmaceutical:
• Radiochemical purity (≥90%)
• Free Indium-111 impurity (≤5%)
• Colloidal Indium-111 impurity (≤5%)
• Specific activity (30–60 MBq/μg)
• pH (4.0–6.0), endotoxins, sterility, heavy metals
⚠️ CRITICAL: Free Indium-111 accumulates in bone marrow and liver!
Colloidal Indium-111 is taken up by the reticuloendothelial system (liver/spleen)!
This creates high physiological background, masking GI and pancreatic tumors.
Usage:
Indium111PentetreotideQualityChecker.exe → demo mode (console output)
Indium111PentetreotideQualityChecker.exe input.csv output.json → evaluate your data
Input format:
BatchNumber,RadiochemicalPurityPercent,FreeIndium111Percent,ColloidalIndium111Percent,SpecificActivityMBqPerUg,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,PeptideConcentrationUgPerVial
Example (sterility: 0=sterile, 1=contaminated):
IN111-PEN-2026-001,94.5,2.5,3.0,45.0,5.2,80.0,0,3,50.0
— WHY IS THIS NEEDED?
Indium-111 Pentetreotide (OctreoScan®) is a radiopharmaceutical for scintigraphy of neuroendocrine tumors (NETs).
• Indium-111 (T½=2.8 days) emits gamma rays (171 and 245 keV).
• Pentetreotide is a synthetic somatostatin analog binding to somatostatin receptors (subtypes 2 and 5) expressed on most NETs.
• "Gold standard" for diagnosing carcinoids, gastrinomas, glucagonomas, etc.
⚠️ CRITICAL:
• Radiochemical purity ≥90% — ensures specific binding to the tumor.
• Free Indium-111 ≤5% — unbound indium gives signal in bones and liver.
• Colloidal Indium-111 ≤5% — hydrolyzed indium is taken up by liver and spleen, which is critical as many NETs are located in this area.
• pH 4.0–6.0 — product is stable in acidic environment (presence of gentisic acid stabilizer).
• Endotoxins ≤175 EU/vial — safety standard.
• Sterility — MANDATORY!
Key features:
• Separate control of free and colloidal indium.
• Specific activity control to ensure high image-to-background contrast.
• Specific pH range for peptide product.
Critical parameters:
• Radiochemical purity: ≥90.0%
• Free Indium-111: ≤5.0%
• Colloidal Indium-111: ≤5.0%
• Specific activity: 30–60 MBq/μg
• pH: 4.0–6.0
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth
• Heavy metals: ≤10 ppm
💡 Usage tips:
1. RCP is determined by TLC.
2. System 1 (ITLC-SG, 0.1 M citric acid): Free In-111 moves with solvent front (Rf=1.0), Conjugate and Colloid stay at origin (Rf=0.0).
3. System 2 (ITLC-SG, 10% NH4OAc:MeOH 1:1): Colloid stays at origin (Rf=0.0), Conjugate and Free move (Rf=1.0).
4. Calculation: % Conjugate = 100% - (% Free + % Colloid).
5. The product must be used within 24 hours after labeling.
⚠️ Note: Pentetreotide is a small peptide (8 amino acids). It is rapidly cleared by kidneys. High impurity of free indium can mimic bone metastases, and colloid can mimic liver involvement. Product purity is critical for correct disease staging.input.csv
BatchNumber,RadiochemicalPurityPercent,FreeIndium111Percent,ColloidalIndium111Percent,SpecificActivityMBqPerUg,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,PeptideConcentrationUgPerVial IN111-PEN-2026-001,94.5,2.5,3.0,45.0,5.2,80.0,0,3,50.0 IN111-PEN-2026-002,89.0,6.0,5.0,42.0,5.5,90.0,0,4,50.0
URS & FS — User Requirements and Functional Specification
This document describes the controlled interface and behaviour of Indium111PentetreotideQualityChecker for Indium-111 Pentetreotide.
Domain limits and critical parameters
- ℹ️ Utility checks critical parameters of the somatostatin analog radiopharmaceutical:
- • Radiochemical purity (≥90%)
- • Free Indium-111 impurity (≤5%)
- • Colloidal Indium-111 impurity (≤5%)
- • pH (4.0–6.0), endotoxins, sterility, heavy metals
- ⚠️ CRITICAL: Free Indium-111 accumulates in bone marrow and liver!
- BatchNumber,RadiochemicalPurityPercent,FreeIndium111Percent,ColloidalIndium111Percent,SpecificActivityMBqPerUg,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,PeptideConcentrationUgPerVial
- Example (sterility: 0=sterile, 1=contaminated):
- ⚠️ CRITICAL:
- • Radiochemical purity ≥90% — ensures specific binding to the tumor.
- • Free Indium-111 ≤5% — unbound indium gives signal in bones and liver.
- • Colloidal Indium-111 ≤5% — hydrolyzed indium is taken up by liver and spleen, which is critical as many NETs are located in this area.
- • Endotoxins ≤175 EU/vial — safety standard.
- • Sterility — MANDATORY!
URS — User Requirements Specification
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The utility shall accept an input.csv file with the exact headers defined in the data contract. | High | The file is processed without manual header editing. |
| URS-002 | The utility shall perform deterministic QC evaluation for Indium-111 Pentetreotide using input values, approved limits and domain rules. | High | Each input row receives a PASS / WARNING / FAIL status. |
| URS-003 | The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility. | High | Schema and conversion errors are explicitly reported. |
| URS-004 | The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present. | High | A critical deviation causes FAIL or a separate critical finding. |
| URS-005 | The utility shall generate output.json with machine-readable results, source values, warnings and failures. | High | JSON is suitable for LIMS/ELN/MES integration and QA/QC review. |
| URS-006 | The utility shall not use machine learning to decide conformance. | Medium | The result is based on explicit rules, thresholds and input values. |
| URS-007 | The utility shall preserve traceability between batch number, input values, applied rules and final status. | High | The output contains the batch identifier and the list of checked parameters. |
| URS-008 | The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators. | Medium | URS & FS, input.csv/output.json contract and test scenarios are supplied with the utility. |
input.csv contract
| # | Field | Type | Sample | Purpose |
|---|---|---|---|---|
| 1 | BatchNumber | string | IN111-PEN-2026-001 | Batch or lot identifier used for traceability. |
| 2 | RadiochemicalPurityPercent | string | 94.5 | Radiochemical purity; confirms the labelled chemical form and binding quality. |
| 3 | FreeIndium111Percent | decimal | 2.5 | Free radionuclide / unbound species; important for non-target uptake and toxicity. |
| 4 | ColloidalIndium111Percent | string | 3.0 | Controlled input parameter used by the deterministic QC rules. |
| 5 | SpecificActivityMBqPerUg | decimal | 45.0 | Radioactivity value used for release, decay or dose-related assessment. |
| 6 | pH | decimal | 5.2 | Solution pH; relevant for stability, compatibility and administration. |
| 7 | EndotoxinsEU | decimal | 80.0 | Bacterial endotoxins; critical for parenteral administration. |
| 8 | SterilityTest | flag / boolean | 0 | Sterility result; critical release parameter. |
| 9 | HeavyMetalsPPM | decimal | 3 | Elemental impurity / metal residue parameter. |
| 10 | PeptideConcentrationUgPerVial | string | 50.0 | Controlled input parameter used by the deterministic QC rules. |
BatchNumber,RadiochemicalPurityPercent,FreeIndium111Percent,ColloidalIndium111Percent,SpecificActivityMBqPerUg,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,PeptideConcentrationUgPerVial IN111-PEN-2026-001,94.5,2.5,3.0,45.0,5.2,80.0,0,3,50.0 IN111-PEN-2026-002,89.0,6.0,5.0,42.0,5.5,90.0,0,4,50.0
FS — Functional Specification
| ID | Function | Implementation |
|---|---|---|
| FS-001 | CSV import | Read input.csv in UTF-8/CSV-compatible format and validate the header and expected columns. |
| FS-002 | Schema validation | Check mandatory fields and column count; report unknown or missing key fields. |
| FS-003 | Type conversion | Convert numeric, flag and text values; invalid formats are recorded as row-level errors. |
| FS-004 | Domain rule engine | Apply domain rules for Indium-111 Pentetreotide, including critical limits from the utility description and approved specification. |
| FS-005 | Status aggregation | Produce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance. |
| FS-006 | JSON export | Write output.json with detailed checks, source values, warnings, failures and critical findings. |
| FS-007 | Audit support | Keep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation. |
| FS-008 | Integration contract | Support the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation. |
Example output.json
{
"utilityId": "indium111-pentetreotide-quality-checker",
"api": "Indium-111 Pentetreotide",
"overallStatus": "PASS|WARNING|FAIL",
"sourceFile": "input.csv",
"checks": [
{
"parameter": "BatchNumber",
"value": "IN111-PEN-2026-001",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "RadiochemicalPurityPercent",
"value": "94.5",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "FreeIndium111Percent",
"value": "2.5",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "ColloidalIndium111Percent",
"value": "3.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "SpecificActivityMBqPerUg",
"value": "45.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "pH",
"value": "5.2",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "EndotoxinsEU",
"value": "80.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "SterilityTest",
"value": "0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": []
}
OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| OQ-001 | Valid sample row | PASS or acceptable WARNING according to the rules. |
| OQ-002 | Mandatory column missing | Schema error or FAIL. |
| OQ-003 | Non-numeric value in numeric field | Type-conversion error. |
| OQ-004 | Critical parameter outside limit | FAIL and critical finding. |
| PQ-001 | User real batch/lot | Reviewed result with input.csv and output.json retained. |
QA/QC and change control
- Do not rename columns without updating the validator and test set.
- Retain
input.csv,output.json, executable version and checksum. - Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
- Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.
Included in packages
Diabetes QC Suite
QC package for diabetes medicines: insulins, metformin, SGLT2/DPP-4/GLP-1 products, glucagon and supporting dosage-form quality checks.
OpenEndocrinology QC Suite
QC package for endocrinology: thyroid, pituitary/peptide hormones, corticosteroids, sex hormones and selected metabolic medicines.
OpenNeurology QC Suite
QC package for neurology and neuropsychiatry: antiepileptics, antiparkinsonian medicines, antidepressants, antipsychotics, analgesics and neurological diagnostic radiopharmaceuticals.
OpenPetRad3: expanded PET/SPECT and radiopharmaceutical QC package
A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.
OpenRadiology QC Suite
QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.
OpenRPH isotope family: labelled cells and blood
In-111 and Cr-51 for labelled cells, blood volume, RBC/WBC and survival workflows.
OpenRPH organ/system: bone and musculoskeletal
Bone scintigraphy, MDP/PYP, marrow, bone-pain palliation, skeletal metastases and radiosynovectomy.
OpenRPH organ/system: brain and CNS
Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.
OpenRPH organ/system: endocrine, thyroid and NET
Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.
OpenRPH organ/system: hepatobiliary and GI
HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.
OpenRPH organ/system: oncology and theranostics
Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.
OpenRPH organ/system: renal and urinary
Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.
OpenRPH use case: PET/SPECT oncology diagnostics and receptor imaging
F-18, Ga-68, Cu-64, Zr-89, In-111 and other diagnostic tracers: synthesis, purity, receptor targeting, immuno-PET and generator-based workflows.
OpenRPH workflow: generators and isotope purity
Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.
OpenRPH workflow: product release QC
Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.
OpenRPH workflow: synthesis, labelling and kit reconstitution
Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.
OpenRPH: combined radiopharmaceutical QC package
RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.
Open